Evidence map›Paper›PMID 40489796›Full record

ArticleBlood advances2025

Prebiotic fiber enteral supplementation after allogeneic transplantation: feasibility and impact on the microbiome.

Sarah Andersen, Glen Kennedy, Merrilyn Banks, Bernadine Flanagan, Andrea Henden

Registry-linked trialAbstract read
In one paragraph

Article in Blood advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07719673 (Enteral Nutrition to Enhance Colonization Resistance Through Gut Microbiota Modulation in Critically Ill Patients), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07719673 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Enteral Nutrition to Enhance Colonization Resistance Through Gut Microbiota Modulation in Critically Ill Patients: A Randomized Controlled Pilot Trial

TypeinterventionalSponsorIuliu Hatieganu University of Medicine and PharmacyRan2026 to 2027Enrolled60ConditionsBacterial Colonization, Multidrug Resistant Organisms, Critical Illness, Gut Microbiota DysbiosisArmsFibre-Enriched Enteral Nutrition, Standard Enteral Nutrition
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Recent advances in the positive role ofFrontiers in immunology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sarah AndersenDietetics and Foodservices, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.ORCID 0000-0002-9200-8186
Glen KennedyCancer Care Services, Royal Brisbane and Women's Hospital, Metro North Hospital and Health Service, Brisbane, QLD, Australia.
Merrilyn BanksDietetics and Foodservices, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.ORCID 0000-0003-4467-4608
Bernadine FlanaganCentre for Nutrition and Food Science, The Queensland Alliance for Agriculture and Food Innovation, The University of Queensland, Brisbane, QLD, Australia.ORCID 0000-0002-5220-190X
Andrea HendenCancer Care Services, Royal Brisbane and Women's Hospital, Metro North Hospital and Health Service, Brisbane, QLD, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

abstractThe decline in diversity of the gastrointestinal microbiome during hematopoietic stem cell transplantation (HSCT) is associated with poorer clinical outcomes. Although provision of enteral nutrition (EN) is common during HSCT, provision of a prebiotic fiber-containing formula has not been explored. This pilot study compared tolerance, clinical, microbiome, and metabolomic outcomes between patients who received standard EN (n = 10) vs prebiotic fiber EN (n = 20) after allogeneic HSCT. Stool samples were collected at baseline and at periengraftment and were analyzed with shotgun metagenomic sequencing. Provision of prebiotic EN increased daily fiber intake after transplant to an average 22 g/d compared with 4 g/d in the standard-care group. High tolerance of both EN formulas was observed with only 20% (n = 2) of the standard and 15% of the prebiotic group (n = 3) requiring parenteral nutrition (P = 1.0). There was no difference in the amount of EN provided, EN duration, or clinical outcomes. Microbial diversity declined in both groups with no difference post-EN provision (P = .93), however, there was a significant difference in relative abundance of Lactobacillus_C rhamnosus, with an increase in the prebiotic group only (P = .022). The relative abundance of Faecalicatena gnavus increased in the standard group and declined in the prebiotic group (P = .0027). Functional analysis of the microbial genome showed decreased expression of antibiotic resistance genes in the prebiotic group only after EN provision (P = .00035). A longer fiber intervention should be trialed to optimize clinical outcomes and a more diverse microbiome. The trial was registered at www.anzctr.org.au as #ACTRN12621000832875.

Indexed as

Dietary FiberEnteral NutritionGastrointestinal MicrobiomeHematopoietic Stem Cell TransplantationPrebioticsAdultFemaleHumansMaleMiddle AgedPilot ProjectsTransplantation, HomologousDietary FiberPrebiotics

Identifiers

PMID40489796
PMCPMC12361784

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.